<DOC>
	<DOCNO>NCT01601210</DOCNO>
	<brief_summary>The purpose study see creatine , naturally occur chemical body , effective treat Major Depressive Disorder ( MDD ) female teenager . The primary hypothesis compare placebo , 2g , 4g , 10g creatine monohydrate eight week associate significant increase brain phosphocreatine ( PCr ) concentration .</brief_summary>
	<brief_title>Dose-Ranging Trial Creatine Augmentation Adolescent Females With Treatment-Resistant Major Depressive Disorder</brief_title>
	<detailed_description>The purpose study see creatine , naturally occur chemical body , effective treat Major Depressive Disorder ( MDD ) female teenager . Creatine may effect interest brain . The reason MRI component study learn new way see inside brain . The investigator use magnetic field radio wave look brain chemical brain . The investigator hope technique medial use future . The primary hypothesis compare placebo , 2g , 4g , 10g creatine monohydrate eight week associate significant increase brain phosphocreatine ( PCr ) concentration . A secondary hypothesis decrease depressive symptom measure Children Depression Rating Scale-Revised ( CDRS-R ) Montgomery Asberg Depression Rating Scale ( MADRS ) reciprocally correlate increase Î²-NTP concentration .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Inclusion criterion : Participants must female . Participants must able grant inform consent ( age &gt; 18 ) , parent/guardian permission plus participant assent ( age &lt; 18 ) . Participants must meet DSMIV criterion MDD , current mood state depress &gt; 2 week . Participants must age 13 21 . Current CDRSR raw score &gt; 40 MADRS score &gt; 25 ; CGIS score &gt; 4 . Participants may enrol individual and/or group psychotherapy , ongoing least 8 week . Participants must treatment SSRI least 8 week , last 4 dosage &gt; equal 20 mg per day fluoxetine equivalent , e.g . 20 mg per day paroxetine , 20 mg citalopram , 10 mg escitalopram , 100 mg sertraline . If participant attempt , could tolerate , dose comparable 20 mg fluoxetine , consider eligible . Exclusion criterion : Unstable comorbid medical , neurological , psychiatric disorder . Current DSMIV criterion substance abuse dependence ( except nicotine/cigarettes ) . Clinically significant suicidal homicidal risk . Preexisting renal disease . Proteinuria baseline urinalysis test . Treatment antiepileptic drug , antipsychotic drug , lithium . Pregnancy breastfeed . Sexually active unwilling practice contraception study . Contraindication magnetic resonance imaging ( e.g . ferromagnetic implant claustrophobia ) History hypersensitivity creatine . History previous fail therapeutic trial creatine . Participants may outpatients inpatient , incarcerated person exclude study approve `` Research Involving Prisoners . ''</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>